[1] 韩雪, 李曼. 微小RNA与肿瘤上皮间质转化[J]. 国际肿瘤学杂志, 2014, 41 (12): 881884. DOI: 10.3760/cma.j.issn.1673422X.2014.12.001.
[2] Nakagawa Y, Akao Y, Taniguchi K, et al. Relationship between expression of oncorelated miRNAs and the endoscopic appearance of colorectal tumors[J]. Int J Mol Sci, 2015, 16(1): 15261543. DOI: 10.3390/ijms16011526.
[3] 赵娜, 张浩, 贺恒鹏. miRNA145在胃癌中的表达及临床意义[J]. 现代肿瘤医学, 2016, 24(11): 17601762. DOI: 10.3969/j.issn.16724992.2016.11.025.
[4] Lee JW, Kim N, Park JH, et al. Differential microRNA expression between gastric cancer tissue and noncancerous gastric mucosa according to Helicobacter pylori status[J]. J Cancer Prev, 2017, 22(1): 3339. DOI: 10.15430/JCP.2017.22.1.33.
[5] 王丹. miRNA145抑制肺癌A549细胞增殖活性的机制[J]. 江苏大学学报: 医学版, 2015, 25(4): 311316. DOI: 10.13312/ j.issn.16717783.y150041.
[6] 何涛, 李国庆, 谢娟, 等. miR145对HepG2细胞中肿瘤干细胞增殖的影响[J]. 中国医药指南, 2013, 11 (31): 6263. DOI: 10.15912/j.cnki.gocm.2013.31.412.
[7] 檀碧波, 李勇, 范立侨, 等. 胃癌组织中miR185检测的临床价值及与Vav3Rac1通路的关系[J]. 河北医药, 2017, 39(17): 25652568, 2572. DOI: 10.3969/j.issn.10027386.2017.17.001.
[8] 王力利, 李勇, 檀碧波, 等. 胃癌及淋巴结组织中miR145的表达水平及其临床意义研究[J]. 中国全科医学, 2016, 19(29): 35583561. DOI: 10.3969/j.issn.10079572.2016.29.010.
[9] Ono H, Imoto I, Kozaki K, et al. Six1 promotes epithelialmesenchymal transition in colorectal cancer through ZEB1 activation[J]. Oncogene, 2012, 31(47): 49234934. DOI: 10.1038/onc.2011.646.
[10] 王密斯, 张荣花, 王琳, 等. miR185对肝癌细胞生长增殖及侵袭迁移的影响[J]. 第三军医大学学报, 2016, 38(17): 19181923. DOI: 10.16016/j.10005404.201601070.
[11] 黄寰, 陆志锋, 陈晞明, 等. miR145通过下调LRRFIP1抑制血管平滑肌细胞增殖及迁移机制[J]. 河北医学, 2017, 23(5): 793796. DOI: 10.3969/j.issn.10066233.2017.05.026.
[12] Terry L, Sheppard. RNA profiling: a better miR trap[J]. Nature Chemical Biology, 2015, 11(11): 828. DOI: 10.1038/nchembio.1942.
[13] Olbromski M, Rzechonek A, Grzegrzolka J, et al. Influence of miR7a and miR243p on the Sox18 transcript in lung adenocarcinoma[J]. Oncol Rep, 2018, 39(1): 201208. DOI: 10.3892/or.2017.6077.
[14] 樊瑞智, 李海青, 曹允友, 等. 微小RNA30a靶向调控Snail影响胃癌SGC7901细胞迁移和侵袭能力[J]. 中华实验外科杂志, 2017, 34(11): 19191921. DOI: 10.3760/cma.j.issn.10019030.2017.11.033.
[15] 赵丽娇, 孙慧, 鲁静, 等. Six1基因异常表达促癌机制及药物靶点[J]. 现代肿瘤医学, 2017, 25(20): 33753378. DOI: 10.3969/j.issn.16724992.2017.20.046.
[16] 曹燕飞, 任睿, 杨晔, 等. miR185靶向Six1对肺癌上皮间质转化过程的影响及其机制[J]. 临床与实验病理学杂志, 2017, 33(8): 879883. DOI: 10.13315/j.cnki.cjcep.2017.08.011.
[17] Chang Y, Yan W, Sun C, et al. miR1455p inhibits epithelialmesenchymal transition via the JNK signaling pathway by targeting MAP3K1 in nonsmall cell lung cancer cells[J]. Oncol Lett, 2017, 14(6): 69236928. DOI: 10.3892/ol.2017.7092.
[18] Chang S, Gao L, Yang Y, et al. MiR145 mediates the antiproliferative and gene regulatory effects of vitamin D3 by directly targeting E2F3 in gastric cancer cells[J]. Oncotarget, 2015, 6(10): 76757685. DOI: 10.18632/oncotarget.3048.
[19] Du P, Zhao J, Wang J, et al. Sine oculis homeobox homolog 1 regulates mitochondrial apoptosis pathway via Caspase7 in gastric cancer cells[J]. J Cancer, 2017, 8(4): 636645. DOI: 10.7150/jca.16018. |